Healthy Skepticism Library item: 3604

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Roizen R.
Why I oppose drug company payment of physician/investigators on a per patient/subject basis
IRB: a review of human subjects research 1988; 10:(1):9-10

Abstract:

The author reviews arguments about whether patients/subjects should be informed about per capita payments to patients and whether such payments are ethical.

Keywords:
*analysis/United States/Institutional Research Board/IRB/drug company sponsored research/doctors/patients/regulation of promotion/conflict of interest/reimbursement to doctors/ATTITUDES REGARDING PROMOTION: HEALTH PROFESSION STUDENTS/ATTITUDES REGARDING PROMOTION: HEALTH PROFESSIONALS/ETHICAL ISSUES IN PROMOTION: GIFT GIVING/ETHICAL ISSUES IN PROMOTION: PAYMENTS IN STUDIES/REGULATION, CODES, GUIDELINES: COMPLIANCE, SANCTIONS, STANDARDS